pentobarbital will decrease the level or effect of buprenorphine, very long-acting injection by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Closely. Clients who transfer to buprenorphine prolonged-performing injection from transmucosal buprenorphine coadministered with CYP3A4 inducers should be monitored to be sure b